REFERENCIAS

1. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: Focas on the serotonin transportar. Clin Chem 1994;40:288-95.
2. Yatham LN, Steiner M. Neuroendocrine probes of serotonergic function. A critical review. Life Sci 1993;53:447-63.
3. Wirz-Justice A Platelet research in psychiatry. Experientia 1988;44:145-51.
4. Da Prada M, Cesura AM, Launay JM, Richards JG. Platelets as a modal for neuronas? Experientia 1988;44:115-26.
5. Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD. Serotonergic markers in platelets of patients with major depression: Upregulation of 5-HT2 receptors. J Psychiatr Neurosci 1995;20:11-9.
6. Mc Bride PA, Brown RP, DeMeo M, Keilp J, Mieczkowski T, Mann JJ. The relationship of platelet 5HT2 receptor indices to major depressive disorder, personalily traits, and suicidal behavior. Biol Psychiatry 1994;35:295-308.
7. Stahl S, Woo D, Mefford Y, Berger P, Ciaranello N. Hyperserotonin uptake and ralease in schizophrenia and affective disorders. Am J Psychiatry 1992;1:321-32.
8. García SevilIa JA; Padró D, Giralt MT, Guimón J, Areso P. Alfa2 adrenoceptor mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Arch Gen Psychiatry 1990;47:125-32.
9. Cerrito F, lazzaro MP, Gaudio E, Arminio P, Aloisi G. 5-HT2-receptors and serotonin ralease: Their role in human platelet aggregation. Life Sci 1993;53:209-15.
10. Mc Bride PA; Mann JJ, Polley MJ, Wiley AJ, Sweeney JA. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets. Life Sci 1987;40:1799-809.
11. Vanags DM, Rodgers SE, Duncan EM, Lloyd JV, Bochner F. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenalina. Br J Pharmacol 1992;106:917-23.
12. Piatraszek MH, Takada Y, Takada A. Effect of Mental stress on platelet aggregation: Possible link to catecholamine levels. Haemostasis 1991;21:346-52.
13. Malyszko J, Urano T, Knofler R, Ihara H, Takada Y, Takada Y. Relationships between serum lipids, serotonin, platelet aggregation and sume fibrinolytic parameters in humans. Life Sci 1994;55:1619-623.
14. Alarayyed NA, Graham BR, Prichard BNC, Smith CCT. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects. Br J Pharmacol 1995;39:369-74.
15. Wood K, Swade C, Abou-Saleh M, Coppen A. Peripheral serotonergic receptor sensitivity in depressive illness. J Affect Disorders 1984;7:59-65.
16. Healy DT, Carney PA; O Halloran A, Leonard BE. Peripheral adrenoceptors and serotonin receptor in depression. J Affect Disorders 1985;9:285-96.
17. Butler J and Leonard BE The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 1988;3:343-47.
18. Brusov O, Beliaev BS, Katasonov AB, Zlobina GL, Factor MI, Lideman RR: Does platelet serotonin supersensitivity accompany endogenous depression? Biol Psychiatry 1989;25:375-81.
19. Mc Adams C, Leonard BE. Changes in platelet aggregatory responses to collagen and 5hydroxytryptarnine in depressed, schizophrenic and manic patients. Int Clin Psychopharmacol 1992;7:81-5.
20. Born GVR. Aggregation of blood platelets by ADP and its reversal. Nature 1962;194:927-29.
21. Mc Adams C, Colohan FJ, Brophy J, Leonard BE. Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression. Biol Psychiatry 1992;32:296-8.
22. Nugent DF, Keeley H, Norman TR, Leonard BE. Investigation of a possible plasma factor in schizophrenia, manic depression, obsessive compulsive disorder and panic disorder. Med Sci Res 1994;22:737-8.
23. Nugent DF, Dinan TG, Leonard BE. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients. J Affect Disorders 1995;33:227-31.